Abstract
Emerging clinical data indicate that dopaminergic agonists used to treat restless legs syndrome may be associated with dopamine dysregulation syndrome, particularly pathological gambling. We report a new case with pathological gambling plus hypersexuality and impotence in an old patient treated with a small dose (0.18 mg daily at bedtime) of pramipexole for restless legs syndrome for 5 months. The time relationship and the resolution upon discontinuation of dopaminergic agonists suggest a causative association. Our new case confirms that restless legs syndrome patients should be cautioned about potential dopamine dysregulation syndrome coinciding with dopaminergic agonists, as it can be reversed by drug withdrawal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Oertel WA, Trenkwalder C, Zucconi M et al (2007) State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Mov Disord 22:S466–S475
Paulus W, Dowling P, Rijsman R et al (2007) Update of the pathophysiology of the restless legs syndrome. Mov Disord 22:S431–S439
American Psychiatric association APA (2004) Diagnostic and statistical manual of mental disorders, 4th edn. Washington
Evans AH, Lawrence AD, Potts J et al (2005) Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 65:1570–1574
Tippmann-Peikert M, Park JG, Boeve BF et al (2007) Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 68:301–303
Quickfall J, Suchowersky O (2007) Pathological gambling associated with dopamine agonist use in restless legs syndrome. Parkinsonism Relat Disord 13:535–536
Evans AH, Butzkueven H (2007) Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis. Mov Disord 22:590–591
Driver-Dunckley ED, Noble BN, Hentz JG et al (2007) Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 30:249–255
Leu-Semenescu S, Karroum E, Brion A, Konofal E, Arnulf I (2009) Dopamine dysregulation syndrome in a patient with restless legs syndrome. Sleep Med 10:494–496
Pourcher E, Rémillard S, Cohen H (2010) Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci 290:52–56
Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH (2010) Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case–control study. Sleep 33:81–87
Grosset KA, Macphee G, Pal G et al (2006) Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 21:2206–2208
Gallagher DA, O’Sullivan SS, Evans AH et al (2007) Pathological gambling in Parkinson’s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22:1757–1763
Uitti RJ, Tanner CM, Rajput AH et al (1989) Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol 12:375–383
Verbaan D, Marinus J, Visser M et al (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69:333–341
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
d’Orsi, G., Demaio, V. & Specchio, L.M. Pathological gambling plus hypersexuality in restless legs syndrome: a new case. Neurol Sci 32, 707–709 (2011). https://doi.org/10.1007/s10072-011-0605-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-011-0605-5